Trending With Impact: Aging Reduced by 8 Years With Rejuvant®

Aging | December 2, 2021
After taking Rejuvant® for approximately 7 months, a recent study revealed that participants experienced an average 8 year reduction in biological aging. continue reading »

Trending With Impact: Worms Reveal Early Event in Neurodegeneration

Aging | November 18, 2021
Researchers examined roundworms to determine the role of mitochondrial dysfunction in progressive neurodegenerative disorders, such as Alzheimer's disease. continue reading »

Trending With Impact: Can Singing Improve Aging?

Aging | November 11, 2021
In a two-year study, researchers compared the effects of choral singing with the effects of health education in an elderly cohort. continue reading »

Dr. Gina Abdelaal – Northumbria University

Oncotarget | December 3, 2021
"The reviewers were extremely professional and all of the comments were very constructive and helped improve the review greatly." continue reading »

Mechanisms of Neoangiogenesis and Tumor Growth UNLOCKED

Oncotarget | December 2, 2021
Researchers conducted a study to elucidate the mechanisms of epithelial-to-mesenchymal transition (EMT) which promote neovascularization in the tumor microenvironment. continue reading »

Behind the Study: EMT, Endothelial Cells & Tumor Growth

Oncotarget | November 29, 2021
Dr. Tapasree Roy Sarkar describes a research paper she co-authored, entitled, "Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growth." continue reading »

Dr. Gina Abdelaal – Northumbria University

Testimonials | December 3, 2021
"The reviewers were extremely professional and all of the comments were very constructive and helped improve the review greatly." continue reading »

Dr. Monica Varun Tyagi – Stanford University

Testimonials | November 25, 2021
"We have previously published in Oncotarget and had a good experience." continue reading »

Dr. Michael Roehrl – Memorial Sloan Kettering Cancer Center

Testimonials | November 19, 2021
"Journal selection is very important for any laboratory and principal investigator who publishes scientific findings. So, our experience with Oncotarget has been really great." continue reading »

Behind the Study: EMT, Endothelial Cells & Tumor Growth

Spotlight | November 29, 2021
Dr. Tapasree Roy Sarkar describes a research paper she co-authored, entitled, "Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growth." continue reading »

Behind the Study: P4HA1 Protein and Colorectal Cancer

Spotlight | November 22, 2021
Dr. Michael Roehrl describes the research paper he co-authored, entitled, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer”. continue reading »

Behind the Study: Benzophenone-3 Promotion of Mammary Tumorigenesis

Spotlight | November 15, 2021
Dr. Richard Schwartz describes the 2020 research paper he co-authored, entitled, “Benzophenone-3 promotion of mammary tumorigenesis is diet-dependent.” continue reading »

Press Release: Aging’s Latest Impact Factor

News | August 20, 2021
In June 2021, Web of Science (Clarivate Analytics) released their 2020 JCR Impact Factor. Aging is pleased to report that our 2020 impact factor is 5.682. continue reading »

Captain of Team Open Access Rides Again for Cancer Research

News | August 18, 2021
Sponsored by Impact Journals, Team Open Access is once again captained by Sergei Kurenov who explains his motivation to participate in the Ride for Roswell. continue reading »

The Ride for Roswell: Rolling Around The Track August 7

News | July 28, 2021
Impact Journals is sponsoring Team Open Access in the annual cycling event to end cancer: The Ride for Roswell. This fundraiser is hosted by Roswell Park Comprehensive Cancer Center in Buffalo, New York. continue reading »